Orally Administered Fisetin Reduces the Symptoms of Acute Allergic Asthma in a Preclinical Mouse Model. Biomedical Research and Therapy, [S. l.], v. 9, n. 3, p. 4953–4970, 2022. DOI: 10.15419/bmrat.v9i3.731. Disponível em: https://preservation.bmrat.org/index.php/BMRAT/article/view/731.. Acesso em: 8 apr. 2025.